Cite
HARVARD Citation
Correa, R. et al. (2022). Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?. Radiotherapy and oncology. pp. 51-56. [Online].